Sonic Healthcare Limited (FRA:SAB)

Market Cap	5.86B -1.5%
Revenue (ttm)	6.58B +12.7%
Net Income	368.34M +18.4%
EPS	0.77 +15.3%
Shares Out	n/a
PE Ratio	15.09
Forward PE	15.46
Dividend	0.66 (5.71%)
Ex-Dividend Date	Sep 2, 2026

Volume	n/a
Open	11.63
Previous Close	11.60
Day's Range	11.63 - 11.63
52-Week Range	11.07 - 14.30
Beta	n/a
Analysts	n/a
Price Target	n/a
Est. Earnings	Nov 18, 2026

About Sonic Healthcare

Sonic Healthcare Limited offers medical diagnostic services, and administrative services and facilities to medical practitioners in Australia, the United States, Germany, and internationally. The company provides laboratory medicine/pathology testing services, such as biochemistry, cytopathology, genetics, haematology, histopathology, immunoserology, microbiology, molecular pathology, prenatal testing, toxicology, and ancillary functions; and radiology services, including magnetic resonance imaging (MRI), computed tomography (CT), ultrasound, X...

• Industry: Diagnostics & Research
• Sector: Healthcare
• Founded: 1934
• Employees: 47,000
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: SAB

Financial Performance

In fiscal year 2026, Sonic Healthcare's revenue was 10.87 billion, an increase of 12.67% compared to the previous year's 9.65 billion. Earnings were 608.29 million, an increase of 18.44%.

Financial numbers in AUD

Data Source: S&P Global Market Intelligence

Fundamental and historical data is provided by S&P Global Market Intelligence.

Last checked:

Oct 25, 2026

Data Sources Report a data error